Skip to main content
. Author manuscript; available in PMC: 2018 Apr 23.
Published in final edited form as: Biometrics. 2015 Sep 22;72(1):39–45. doi: 10.1111/biom.12412

Table 3.

Death due to worsening heart failure by treatment and gender.

Group Yes (%) No (%) Total
male-placebo (M-P) 358 (13.6) 2281 (86.4) 2639
male-drug (M-D) 300 (11.4) 2342 (88.6) 2642
female-placebo (F-P) 91 (11.9) 673 (88.1) 764
female-drug (F-D) 94 (12.5) 661 (87.5) 755